114 related articles for article (PubMed ID: 3804580)
1. Cisplatin nephrotoxicity: symptomatic hypomagnesemia and renal failure.
Gomez Campdera FJ; Gonzalez P; Carrillo A; Estelles MC; Rengel M
Int J Pediatr Nephrol; 1986; 7(3):151-2. PubMed ID: 3804580
[TBL] [Abstract][Full Text] [Related]
2. Acute renal tubular dysfunction following cis-dichlorodiammine platinum therapy.
Davis S; Kessler W; Haddad BM; Maesaka JK
J Med; 1980; 11(2-3):133-41. PubMed ID: 6931873
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced hypocalcemia and hypomagnesemia.
Lyman NW; Hemalatha C; Viscuso RL; Jacobs MG
Arch Intern Med; 1980 Nov; 140(11):1513-4. PubMed ID: 7192079
[TBL] [Abstract][Full Text] [Related]
4. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure.
Bennett WM; Pastore L; Houghton DC
Cancer Treat Rep; 1980; 64(8-9):921-4. PubMed ID: 6160913
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin-induced cardiomyopathy aggravated by cis-platinum nephrotoxicity requiring dialysis.
Tay HN; Yap HK; Murugasu B; Quah TC; Tay SH; Lim JW
J Singapore Paediatr Soc; 1990; 32(3-4):125-8. PubMed ID: 1966850
[TBL] [Abstract][Full Text] [Related]
6. Irreversible renal failure after intraperitoneal cisplatin administration. A case report.
Gouge SF; Tietjen DP; Moore J
J Reprod Med; 1989 Nov; 34(11):931-3. PubMed ID: 2585396
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin nephrotoxicity.
Meyer KB; Madias NE
Miner Electrolyte Metab; 1994; 20(4):201-13. PubMed ID: 7845323
[TBL] [Abstract][Full Text] [Related]
8. Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature.
Al-Tweigeri T; Magliocco AM; DeCoteau JF
Gynecol Oncol; 1999 Jan; 72(1):120-2. PubMed ID: 9889044
[TBL] [Abstract][Full Text] [Related]
9. Acute renal failure due to cisplatin.
De Santo NG; Capasso G; Capodicasa G; Tancredi F; Nuzzi F; Giordano C
Int J Pediatr Nephrol; 1986; 7(3):145-50. PubMed ID: 3804579
[TBL] [Abstract][Full Text] [Related]
10. [Hypomagnesemia in patients of gynecologic neoplasms following chemotherapy with cisplatin].
Li L; Huang W; Zhu B
Zhonghua Fu Chan Ke Za Zhi; 1995 Jun; 30(6):363-5. PubMed ID: 7555373
[TBL] [Abstract][Full Text] [Related]
11. [A case of second-degree atrioventricular block caused by high dose cisplatin treatment].
Tasaka T; Fujita J; Futami H; Yamaji Y; Hata Y; Bungo M; Nakamura H; Shiotani T; Irino S
Gan To Kagaku Ryoho; 1991 May; 18(6):1047-50. PubMed ID: 2029191
[TBL] [Abstract][Full Text] [Related]
12. [Acute renal failure after the use of cis-diamminedichloroplatinum, gentamycin and cephalosporins].
Leite JB; Gentil Fde C; Burchenal J; Marques A; Teixeira MI; Abrão FS
Rev Paul Med; 1981; 97(4-6):75-7. PubMed ID: 7199754
[No Abstract] [Full Text] [Related]
13. Refractory potassium repletion due to cisplatin-induced magnesium depletion.
Rodriguez M; Solanki DL; Whang R
Arch Intern Med; 1989 Nov; 149(11):2592-4. PubMed ID: 2818117
[TBL] [Abstract][Full Text] [Related]
14. High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).
De Jager R; Longeval E; Klastersky J
Cancer Treat Rep; 1980; 64(12):1341-6. PubMed ID: 6258791
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin nephrotoxicity in a patient with a single kidney.
Udeani GO; Singh K; Mullane MR; Lad TE
Ann Pharmacother; 1996; 30(7-8):782-6. PubMed ID: 8826561
[TBL] [Abstract][Full Text] [Related]
17. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine.
Sastry J; Kellie SJ
Pediatr Hematol Oncol; 2005; 22(5):441-5. PubMed ID: 16020136
[TBL] [Abstract][Full Text] [Related]
18. [The evaluation of single administration of cisplatin in non-small cell carcinoma of the lung].
Matsuoka R; Kira S; Watanabe S; Nagao K; Inatomi K; Honma H
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1407-12. PubMed ID: 4040352
[TBL] [Abstract][Full Text] [Related]
19. [Definitive end-stage chronic kidney failure after cisplatin treatment].
Brillet G; Deray G; Lucsko M; Faucher C; Aubert P; Rottembourg J; Jacobs C
Nephrologie; 1993; 14(5):227-9. PubMed ID: 8159252
[TBL] [Abstract][Full Text] [Related]
20. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
